Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia.

Jinsong SuZixuan LiuChuan LiuXuanhao LiYi WangJing ZhaoQingjiang WuShi-Chao Zheng Yi Zhang

Published in: Evidence-based complementary and alternative medicine : eCAM (2020)

The network pharmacological strategy integrated molecular docking to explore the mechanism of action of AHI against COVID-19. It provides protein targets associated with COVID-19 that may be further tested as therapeutic targets of anisodamine.

Keyphrases

molecular docking
coronavirus disease
sars cov
molecular dynamics simulations
respiratory syndrome coronavirus
amino acid
intensive care unit
network analysis
small molecule